J Clin Gastroenterol
October 2021
Background & Aims: Endoscopic submucosal dissection (ESD) is effective and safe for the removal of neoplastic lesions in the general population, but its role in patients with cirrhosis is not clear. We evaluated data on feasibility and safety of ESD for gastric lesions in cirrhotic patients.
Methods: A systematic review of the literature with pooled-data analysis was performed.
Objectives: Efficacy of symbiotics in patients with irritable bowel syndrome (IBS) remains unknown.
Methods: Patients were randomized to a prebiotic (n=135), or a symbiotic formulation containing Lactobacillus paracasei B21060 (Flortec, n=132). Primary efficacy was the responder rate for pain and global relief of symptoms in the overall population and in patients with predominant diarrhea (n=47).